# K123377: Target Detachable Coil

- Pathway: 510(k) (Special)
- Applicant: Stryker Neurovascular
- Decided: Nov 30, 2012 after 29 days
- Product code: HCG (Device, Neurovascular Embolization)
- Device class: 2
- Regulation: 21 CFR 882.5950
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 11 generations back to K951256 (1995). 37 ancestors in all.
12 later devices descend from it; 1 cites it directly.
0 of 50 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K102672: Target Detachable Coil, Boston Scientific Corp (2010) Summary page 2.
- K112385: Traget Detachable Coil, Stryker Neurovascular (2011) Summary page 4.
- K113412: Target Detachable Coil, Stryker Neurovascular (2011) Summary page 5.

## Most influential descendants
- K153658: Target Detachable Coils (2016), 11 descendants of its own
- K161429: Target Detachable Coils (2016), 10 descendants of its own
- K222533: Target Tetra Detachable Coils (2022), 3 descendants of its own
- K203625: Numen Coil Embolization System; NumenFR Detachment System (2021), 3 descendants of its own
- K242243: Target Detachable Coils (2024), 2 descendants of its own

## Indications for use
Target Detachable Coils are indicated for the endlovascular embolization of: * Intracranial aneurysms * Other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulae * Arterial and venous embolizations in the peripheral vasculature

Source page: https://510kreport.com/device/K123377
Methodology: https://510kreport.com/methodology